We are live on
!
Find out more
GC
Guggenheim Capital Portfolio holdings
AUM
$12.9B
1-Year Est. Return
27.3%
This Fund
S&P 500
This Quarter
Est. Return
+5.8%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.2B
AUM Growth
-$360M
(-0.85%)
Cap. Flow
-$2.32B
Cap. Flow
% of AUM
-5.5%
Top 10 Holdings %
Top 10 Hldgs %
7.6%
Holding
2,945
New
147
Increased
1,226
Reduced
1,320
Closed
236
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$859M |
| 2 |
Apple
AAPL
|
+$61.2M |
| 3 |
Norwegian Cruise Line
NCLH
|
+$56M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.7M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$106M |
| 2 |
ULQ
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
|
+$84.5M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$53.6M |
| 4 |
Applied Materials
AMAT
|
+$37.5M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.48% |
| 2 | Financials | 12.95% |
| 3 | Healthcare | 12.03% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Ironwood Pharmaceuticals
IRWD
$696M
| $2.77M | 0.01% |
220,415
-57,011
| -21% | -$745K |
|
1427
Scansource
SCSC
$1.15B
| $2.77M | 0.01% |
77,340
+2,918
| +4% | +$114K |
|
1428
State Street SPDR Dow Jones International Real Estate ETF
RWX
$269M
| $2.77M | 0.01% |
68,336
+2,747
| +4% | +$107K |
|
|
PERY
1429
DELISTED
Perry Ellis International Inc
PERY
| $2.76M | 0.01% |
110,266
+29,619
| +37% | +$706K |
|
1430
BGC Group
BGC
$5.45B
| $2.76M | 0.01% |
284,061
-321,660
| -53% | -$3.25M |
|
|
PCQ
1431
Pimco California Municipal Income Fund
PCQ
$163M
| $2.76M | 0.01% |
159,651
-87,110
| -35% | -$1.5M |
|
1432
Corpay
CPAY
$25B
| $2.76M | 0.01% |
14,336
-428
| -3% | -$75.3K |
|
1433
Kinross Gold
KGC
$27.4B
| $2.75M | 0.01% |
636,820
-97,313
| -13% | -$405K |
|
|
ESV
1434
DELISTED
Ensco Rowan plc
ESV
| $2.75M | 0.01% |
116,319
+34,028
| +41% | +$754K |
|
|
MDCO
1435
DELISTED
Medicines Co
MDCO
| $2.74M | 0.01% |
100,424
-23,318
| -19% | -$718K |
|
|
OPLN
1436
Openlane
OPLN
$4.21B
| $2.74M | 0.01% |
143,429
-134,911
| -48% | -$2.5M |
|
|
BPMC
1437
DELISTED
Blueprint Medicines
BPMC
| $2.74M | 0.01% |
+36,346
| New | +$2.56M |
|
1438
Enpro
NPO
$6.63B
| $2.73M | 0.01% |
+29,247
| New | +$2.48M |
|
1439
MDU Resources
MDU
$4.17B
| $2.73M | 0.01% |
266,618
-436,608
| -62% | -$4.47M |
|
1440
Fox Factory Holding Corp
FOXF
$755M
| $2.72M | 0.01% |
70,132
+6,315
| +10% | +$255K |
|
1441
Plains GP Holdings
PAGP
$5.21B
| $2.72M | 0.01% |
123,979
-5,647
| -4% | -$119K |
|
|
NTRI
1442
DELISTED
NutriSystem, Inc.
NTRI
| $2.72M | 0.01% |
51,710
-42,273
| -45% | -$2.22M |
|
|
CGO
1443
Calamos Global Total Return Fund
CGO
$125M
| $2.72M | 0.01% |
181,427
-60,953
| -25% | -$857K |
|
|
GHY
1444
PGIM Global High Yield Fund
GHY
$478M
| $2.71M | 0.01% |
188,204
+8,399
| +5% | +$123K |
|
1445
KNOT Offshore Partners
KNOP
$372M
| $2.7M | 0.01% |
130,057
-4,598
| -3% | -$99.5K |
|
|
HRG
1446
DELISTED
HRG Group, Inc.
HRG
| $2.69M | 0.01% |
158,807
-23,251
| -13% | -$375K |
|
|
WWE
1447
DELISTED
World Wrestling Entertainment
WWE
| $2.68M | 0.01% |
87,806
+36,291
| +70% | +$981K |
|
|
LNCE
1448
DELISTED
Snyders-Lance, Inc.
LNCE
| $2.68M | 0.01% |
53,573
-4,268
| -7% | -$169K |
|
|
SNBR
1449
DELISTED
Sleep Number
SNBR
| $2.68M | 0.01% |
+71,225
| New | +$2.43M |
|
1450
Mercury Insurance
MCY
$5.93B
| $2.67M | 0.01% |
50,034
+7,360
| +17% | +$405K |
|
Similar funds
TRSOTSOK
AIM
CII
AAMU
NMIFOAC
WANY
ACA
Guggenheim Capital's Q4 2017 Portfolio in Review
As of Q4 2017, Guggenheim Capital held 2,945 positions worth $42.2B, down 0.85% from $42.6B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
Guggenheim Capital withdrew a net $2.32B in Q4 2017, closing 236 positions and reducing 1,320 holdings. Its most notable exit was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF, an estimated $84.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Guggenheim Capital opened a new position in iShares China Large-Cap ETF worth $18M.
- Guggenheim Capital's largest Q4 2017 buy was iShares China Large-Cap ETF: 389,755 shares worth $18M.
- Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, an estimated $859M increase.
- Guggenheim Capital's biggest Q4 2017 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $106M.
- Guggenheim Capital fully exited CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF in Q4 2017, selling an estimated $84.5M.
- Guggenheim Capital's ten largest holdings make up 7.6% of its $42.2B portfolio in Q4 2017.
- Guggenheim Capital opened 147 new positions and closed 236 in Q4 2017.
- Guggenheim Capital's portfolio value fell 0.85% quarter-over-quarter to $42.2B.
Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.